Quince Therapeutics, Inc. (QNCX)
3.09
-0.26
(-7.76%)
USD |
NASDAQ |
Jan 02, 12:22
Quince Therapeutics EPS Diluted (Quarterly): -0.2492 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Masimo Corp. | -1.859 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.44M |
| Total Expenses (Quarterly) | 13.44M |
| Enterprise Value | 178.24M |
| Earnings Yield | -39.45% |
| Normalized Earnings Yield | -32.92 |